We are live on
!
Find out more
SIP
Stoneridge Investment Partners Portfolio holdings
AUM
$138M
1-Year Est. Return
7.66%
This Fund
S&P 500
This Quarter
Est. Return
+7.31%
1 Year Est. Return
+7.66%
3 Year Est. Return
+26.37%
5 Year Est. Return
+15.44%
10 Year Est. Return
+55.31%
AUM
$217M
AUM Growth
+$16.6M
(+8.3%)
Cap. Flow
+$4.19M
Cap. Flow
% of AUM
1.93%
Top 10 Holdings %
Top 10 Hldgs %
36.04%
Holding
132
New
21
Increased
23
Reduced
25
Closed
21
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Baxter International
BAX
|
+$2.94M |
| 2 |
Citigroup
C
|
+$2.88M |
| 3 |
Lam Research
LRCX
|
+$2.41M |
| 4 |
Salesforce
CRM
|
+$2.25M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$2.11M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$5.14M |
| 2 |
Starbucks
SBUX
|
+$2.61M |
| 3 |
W.R. Berkley
WRB
|
+$2.25M |
| 4 |
Hershey
HSY
|
+$2.14M |
| 5 |
Dollar General
DG
|
+$2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.19% |
| 2 | Communication Services | 12.29% |
| 3 | Financials | 11.61% |
| 4 | Healthcare | 11.04% |
| 5 | Consumer Discretionary | 10.38% |
Similar funds
DW
PF
AFW
RC
CPW
SMA
LDNAM
MFF
Stoneridge Investment Partners's Q4 2021 Portfolio in Review
As of Q4 2021, Stoneridge Investment Partners held 132 positions worth $217M, up 8.3% from $200M the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Stoneridge Investment Partners's Q4 2021 filing shows 21 new, 23 increased, 25 reduced and 21 closed positions. Its largest new stake was Lam Research: 38,440 shares worth $2.76M. The largest sale was Merck, an estimated $5.14M.
By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 27% a quarter earlier, followed by Communication Services and Financials.
- Stoneridge Investment Partners's largest Q4 2021 buy was Lam Research: 38,440 shares worth $2.76M.
- Stoneridge Investment Partners added most to Baxter International in Q4 2021, an estimated $2.94M increase.
- Stoneridge Investment Partners's biggest Q4 2021 reduction was W.R. Berkley, cutting an estimated $2.25M.
- Stoneridge Investment Partners fully exited Merck in Q4 2021, selling an estimated $5.14M.
- Stoneridge Investment Partners's ten largest holdings make up 36% of its $217M portfolio in Q4 2021.
- Stoneridge Investment Partners opened 21 new positions and closed 21 in Q4 2021.
- Stoneridge Investment Partners's portfolio value rose 8.3% quarter-over-quarter to $217M.
Based on Stoneridge Investment Partners's 13F filing for Q4 2021, filed 2 Feb 2022.